Article
Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation.
Journal of hepatology - 1 Apr 2014
Senkerikova Renata, de Mare-Bredemeijer Emmeloes, Frankova Sona, Roelen Dave, Visseren Thijmen, Trunecka Pavel, Spicak Julius, Metselaar Herold, Jirsa Milan, Kwekkeboom Jaap, Sperl Jan
Abstract excerpt
BACKGROUND & AIMS: Augmented susceptibility to infections increases mortality in patients with end-stage liver disease (ESLD). We sought to determine the contribution of selected genetic variants involved in inflammatory signalling downstream of the Toll-like receptor 4 (TLR4) to severe bacterial infections (SBIs) in patients with ESLD. METHODS: We retrospectively assessed incidence of SBIs in 336 adult ESLD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
